Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

atnahs pharma australia pty ltd - granisetron hydrochloride, quantity: 2.24 mg (equivalent: granisetron, qty 2 mg) - tablet, film coated - excipient ingredients: magnesium stearate; microcrystalline cellulose; lactose monohydrate; sodium starch glycollate; hypromellose; titanium dioxide; polysorbate 80; macrogol 400 - adults: kytril (tablets and injection) is indicated for use in adults for: the prevention of nausea and vomiting induced by cytotoxic chemotherapy; the prevention of nausea and vomiting induced by radiotherapy.

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

atnahs pharma australia pty ltd - famciclovir, quantity: 125 mg - tablet, film coated - excipient ingredients: magnesium stearate; lactose; hyprolose; sodium starch glycollate; titanium dioxide; hypromellose; macrogol 6000; macrogol 4000 - famvir is indicated for the treatment of herpes zoster infection in adult patients who commence therapy within 72 hours of the onset of the rash. greatest benefit occurs if the drug is started within 48 hours. efficacy has not been demonstrated in patients less than 50 years of age, although the occasional younger patient with severe herpes zoster may benefit from therapy with famciclovir. herpes zoster is generally a milder condition in younger patients. famvir is also indicated in the treatment of recurrent episodes of genital herpes in adults and adolescents 12 years of age and older. famvir is also indicated for suppression of recurrent genital herpes. famvir is also indicated for the treatment of recurrent herpes labialis (cold sores) in immunocompetent patients famvir is also indicated in immunocompromised patients for: treatment of uncomplicated herpes zoster; treatment of recurrent herpes simplex; suppression of recurrent herpes simplex

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

atnahs pharma australia pty ltd - famciclovir, quantity: 250 mg - tablet, film coated - excipient ingredients: sodium starch glycollate; lactose; magnesium stearate; hyprolose; titanium dioxide; hypromellose; macrogol 6000; macrogol 4000 - famvir is indicated for the treatment of herpes zoster infection in adult patients who commence therapy within 72 hours of the onset of the rash. greatest benefit occurs if the drug is started within 48 hours. efficacy has not been demonstrated in patients less than 50 years of age, although the occasional younger patient with severe herpes zoster may benefit from therapy with famciclovir. herpes zoster is generally a milder condition in younger patients. famvir is also indicated in the treatment of recurrent episodes of genital herpes in adults and adolescents 12 years of age and older. famvir is also indicated for suppression of recurrent genital herpes. famvir is also indicated for the treatment of recurrent herpes labialis (cold sores) in immunocompetent patients famvir is also indicated in immunocompromised patients for: treatment of uncomplicated herpes zoster; treatment of recurrent herpes simplex; suppression of recurrent herpes simplex

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

atnahs pharma australia pty ltd - naproxen, quantity: 750 mg - tablet, modified release - excipient ingredients: sunset yellow fcf; hypromellose; purified water; magnesium stearate - rheumatoid arthritis, osteoarthritis, ankylosing spondylitis and the relief of chronic pain states in which there is an inflammatory component.

Örményország - angol - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

f. hoffmann-la roche ltd. - ibandronic acid (ibandronic acid monosodium monohydrate) - tablets film-coated - 150mg

Európai Unió - angol - EMA (European Medicines Agency)

atnahs pharma netherlands b.v. - solriamfetol hydrochloride - narcolepsy; sleep apnea, obstructive - psychoanaleptics, - sunosi is indicated to improve wakefulness and reduce excessive daytime sleepiness in adult patients with narcolepsy (with or without cataplexy).sunosi is indicated to improve wakefulness and reduce excessive daytime sleepiness (eds) in adult patients with obstructive sleep apnoea (osa) whose eds has not been satisfactorily treated by primary osa therapy, such as continuous positive airway pressure (cpap). 

Málta - angol - Medicines Authority

waymade bv herikerbergweg 88, 1101cm amsterdam , netherlands - dexamfetamine sulfate - tablet - dexamfetamine sulfate 5 mg - psychoanaleptics

Írország - angol - HPRA (Health Products Regulatory Authority)

atnahs pharma netherlands b.v. - lisinopril dihydrate; hydrochlorothiazide - tablet - 10 mg/12.5 milligram(s) - ace inhibitors and diuretics; lisinopril and diuretics

Írország - angol - HPRA (Health Products Regulatory Authority)

atnahs pharma netherlands b.v. - hydrochlorothiazide; lisinopril anhydrous - tablet - 20 mg/12.5 milligram(s) - ace inhibitors and diuretics; lisinopril and diuretics

Írország - angol - HPRA (Health Products Regulatory Authority)

atnahs pharma netherlands b.v. - lisinopril - tablet - 10 milligram(s) - ace inhibitors, plain; lisinopril